Form 4: Roper Technologies CEO Laurence Hunn Executes Stock Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Roper Technologies' CEO, Laurence Neil Hunn, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan on November 8, 2024.

Summary

  • On November 8, 2024, Laurence Neil Hunn, the President and CEO of Roper Technologies, exercised employee stock options to acquire 30,000 shares of common stock at a price of $156.40 per share.
  • Simultaneously, Hunn sold a total of 30,000 shares of Roper Technologies' common stock in multiple transactions at weighted average prices ranging from $571.98 to $575.91.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan.
  • Following these transactions, Hunn directly owns 87,311 shares of common stock and indirectly owns 92,808 shares through a limited partnership.

Sentiment

Score: 5

Explanation: The document reflects routine insider trading activity under a pre-arranged plan, indicating a neutral sentiment.

Industry Context

This filing is a routine disclosure of insider transactions. It is common for executives to utilize 10b5-1 trading plans to diversify their holdings and avoid accusations of trading on inside information. The sale represents a small percentage of the CEO's overall holdings.

Comparison to Industry Standards

  • Executive compensation packages often include stock options as a significant component.
  • Rule 10b5-1 trading plans are a standard practice among corporate executives to manage their stock sales in a transparent and compliant manner.
  • Comparing Hunn's transactions to those of CEOs at similar companies (e.g., Danaher, Fortive) would require analyzing their respective Form 4 filings and compensation structures.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
  • The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
11/17/2014Date options were granted.
11/17/201650% of options vested.
11/17/2017Remaining 50% of options vested.
11/08/2024Date of stock option exercise and stock sales.
11/12/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.